Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
In vitro Inhibition of Leishmania braziliensis Promastigotes Growth by a Fluconazole Microemulsion
Cutaneous leishmaniasis (CL) is the most prevalent form of the disease caused by the parasites Leishmania. However, effective topical treatments for the disease are lacking. Fluconazole (FLZ) is an antifungal agent that inhibits a key enzyme for the production of ergosterol, the main sterol in membranes of fungi and parasites. An in vitro eval... Read More»
Claudia Salerno, Adriana M Carlucci, Susana Gorzalczany and Carlos Bregni
Research Article: J Mol Pharm Org Process Res 2014, 2:115
DOI: 10.4172/2329-9053.1000115
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
An Old Drug for the Modern Treatment of Leishmaniasis
Claudia Salerno and Carlos Bregni
Editorial: J Mol Pharm Org Process Res 2014, 2:e114
Lipid-based Microtubes: A Promising Drug Carrier
Claudia Salerno and Carlos Bregni*
Short Communication: J Mol Pharm Org Process Res 2013, 1:103
Nanomedicines in Cancer Therapy
Carlos Bregni* and Adriana Carlucci
Short Communication: J Mol Pharm Org Process Res 2013, 1:101
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals